CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
The main purpose of this study is to test an investigational drug known as VYD2311, which is being developed to lower the risk of getting COVID...
Phase 3
Long Beach, California, United States and 19 other locations
IV compared to remdesivir IV alone for the treatment of symptomatic COVID-19 in severely immunocompromised adult participants who a...
Phase 3
Granada Hills, California, United States and 157 other locations
This is a Phase II multi-center, double-blind, placebo-controlled, randomized study in Patients with moderate to severe lung injury due to COVID...
Phase 2
Santa Monica, California, United States and 1 other location
vaccine for the prevention of symptomatic Coronavirus Disease 2019 (COVID-19).In order to represent a more recently circulating SAR...
Phase 2
Los Angeles, California, United States and 145 other locations
This is a Phase 4, post-market US study, evaluating the efficacy and safety of a single dose of the NVX-CoV2705 Omicron JN.1 COVID-19...
Phase 4
Inglewood, California, United States and 98 other locations
seek to enroll immunocompromised patients with Lower Tract parainfluenza infection.It also contains a sub-study to enroll patients with severe COVID...
Phase 3
Duarte, California, United States and 28 other locations
Researchers are looking for other ways to prevent severe illness from COVID-19. COVID-19 is a virus that most oft-...
Phase 3
Northridge, California, United States of America and 224 other locations
The purpose of the study is to evaluate whether ibuzatrelvir is effective and safe in adults and adolescents with COVID-19 who do n...
Phase 3
Los Angeles, California, United States and 259 other locations
study treatment works in the study) of the study medicine (called nirmatrelvir/ritonavir) for potential treatment of coronavirus disease 2019 (COVID...
Phase 3
Los Angeles, California, United States and 75 other locations
COVID-19 vaccination among patients at high risk for severe disease has declined in the United States since 2022. Prior research, i...
Pasadena, California, United States
Clinical trials
Research sites
Resources
Legal